Get started

OSCR

Bullish Thesis: Why Oscar Health OSCR Could Rally Strong in 2025Oscar Health, OSCR, a technology-driven health insurance company, is positioned for a significant stock price appreciation in 2025. Despite some mixed short-term sentiment, the long-term outlook and recent analyst forecasts suggest a potential rally that could more than double the current share price. Here’s why OSCR could be a compelling bullish opportunity this year: 1. Strong Analyst Price Targets Indicate Upside of Over 125% According to recent forecasts, OSCR is expected to reach an average price of $31.40 in 2025, with some analysts projecting highs as much as $41.31—a potential upside exceeding 125% from the current price near $13.95. Monthly forecasts show a steady upward trajectory, with July 2025 targets around $37.24 and December 2025 targets near $34.67, highlighting sustained bullish momentum throughout the year. The average 12-month price target is around $34.40, representing a 146% upside, signaling strong confidence in OSCR’s growth prospects. 2. Innovative Business Model and Growth Potential Oscar Health leverages technology and data analytics to offer user-friendly, transparent health insurance plans, differentiating itself in a traditionally complex industry. Its focus on member engagement, telemedicine, and cost-effective care management positions it well to capture market share as healthcare consumers increasingly demand digital-first solutions. The company’s expanding footprint in both individual and Medicare Advantage markets provides multiple growth avenues. 3. Long-Term Vision and Market Opportunity Beyond 2025, forecasts remain highly bullish, with OSCR projected to reach $53.77 by 2027 and nearly $100 by 2030, reflecting strong secular growth potential in the health insurance and digital health sectors. Analysts see Oscar as a disruptive force with the potential to reshape healthcare delivery, driving substantial long-term shareholder value. 4. Improving Financial Metrics and Operational Execution Oscar has been improving its loss ratios and operating efficiencies, which are critical for sustainable profitability. The company’s investments in technology infrastructure and data-driven care management are expected to translate into better margins and revenue growth over time. 5. Market Sentiment and Analyst Ratings While some platforms show mixed short-term sentiment, the dominant analyst consensus is a "Buy" or "Moderate Buy," supported by strong price targets and growth forecasts. The stock’s current undervaluation relative to its growth potential creates a favorable risk-reward profile for investors.
NYSE:OSCRLong
by TopgOptions
What's going on with $OSCR? Let's break it down!🚨 What's going on with NYSE:OSCR ? Let's break it down! 👇 📌 Long-term investors: Every dip = buy/add opportunity 📌 Traders: Short term, we may fill the $13.31 GAP 🔹 Massive volume shelf & consolidation between $11-$17 for nearly 2 years—the bigger the base, the bigger the breakout! 🔹 Rising trendline since April lows—if this breaks, expect a move to $13.31 GAP, possibly $11-$12. Strong support here unless bad news or a market correction hits. 🔹 Break above $18.27 (earnings pop) = 🚀 $20+ short term 🔹 200DMA rejection after retest from below = bearish short term 🔹 WR% is making a lower low instead of swinging higher—watching this closely. 🧐 Overall: We’re in a consolidation phase—when it moves, expect it to be quick & explosive 🔥 Best strategy: DCA & wait for the inevitable surge to $20+ (barring major setbacks). Stay patient. Stay focused. NYSE:OSCR ’s move is coming! 💪
NYSE:OSCRLong
by RonnieV29
OSCR 1W — When the Chart Speaks Before the FundamentalsThe Oscar Health chart is currently forming a textbook cup and handle — a long-term reversal structure that has completed its base and is now breaking out of the consolidation zone. The bullish structure is confirmed through price action, volume, and positioning relative to key moving averages. The price has broken through the upper boundary of the handle, shaped as a descending wedge. The breakout is accompanied by increased volume — a clear sign of capital rotation out of accumulation. All major moving averages (EMA, MA50, MA200, WMA) are trending upward, and the price is holding above them all, confirming the bullish momentum. According to Fibonacci extension levels, drawn from the historical low of $1.50 to the peak near $23.26, the first wave target stands at $36.71 (1.618 level), with an extended target at $45.02 (2.0 level). Structurally, the setup suggests a medium-term scenario pointing from current levels toward the $36–45 range, with the potential to repeat the kind of explosive move seen during the 2023 phase, when the price increased more than sixfold. On the fundamental side, Oscar Health is actively recovering: in 2024, revenue grew by more than 50%, net losses were cut nearly in half, and the client base continued to expand. The company is strengthening its share in the digital insurance market and gaining support from institutional investors, including Morgan Stanley and Capital Group. The latest quarterly report was positively received. The breakout is technically clean and fundamentally supported. The immediate pullback zones sit at $14.95 and $13.40. Below that, moving averages may act as control zones for reaction.
NYSE:OSCRLong
by TotoshkaTrades
$OPFI ABOUT TO RUN 108%?! MASSIVE PotentialNYSE:OPFI ABOUT TO RUN 108%?!!! 🤯 Rounded Bottom with a Hammer Candle as a Cherry on Top! 🍒 My Price Targets are ATHs and $22 🎯 - Rounded bottom on daily repeating last move - Rounded bottom on Monthly Chart with a breakout/ Retest/ now a confirmation of higher if we hold this week higher! - About to make a Bullish Cross on the - H5_S Indicator (Still Bullish on H5_M Indicator) - Volume Shelf Gap fill to 12 then 14 - Consistent buying volume. Sellers may be exhausted here - Daily WCB formed giving us added insurance against the downside Most of all MASSIVE Buying Volume today which eclipses the last 2 weeks of volume! Not Financial Advice
NYSE:OPFILong
by RonnieV29
OSCR - This could be MASSIVE!NYSE:OSCR Still doing my DD on this name but here are my thoughts on the technical side of the house. Monthly Chart Analysis: CupnHandle Breakout = $45 🎯 Bullish: - CupnHandle forming - At the first Volume Shelf with a GAP above - In a bullish up trend - Michael Burry bought at current prices Bearish: - S/R zone range is $10-$13.50 - Volume GAP down to $10ish - Bottom of Bullish channel is $10ish - Wr% is down-trending My Opinion: - I believe we will more than likely form a deeper handle due to the fact that the Wr% is down-trending. I've found that when we break above -20 and then start a bearish channel descent we get to -80 or to the green support beam before we bottom out and then bounce to the opposite end of the spectrum. - This would bring us into the $10-12 range before we see a bounce. - I believe this to be the case as we now have a red H5 Indicator that is almost making a bearish cross as well. As I said I'm still doing my Fundamental DD on this name but if it does turn out to be fundamentally undervalued with a bright future then I would welcome this to fall further in order to buy more. Not financial advice
NYSE:OSCRLong
by RonnieV29
3
🏥💡 Oscar Health (OSCR) Analysis 📈🔍Market Disruption: Oscar Health NYSE:OSCR is at the forefront of revolutionizing the health insurance industry through technological innovation, significantly enhancing market reach and member experience. Expansion Plans: In 2024, Oscar Health aims to introduce new technology-enabled plans across 165 new counties spanning 11 states. These initiatives prioritize accessibility, affordability, and personalized member experiences, aimed at driving premium growth. Innovative Programs: The company's +Oscar program, catering to 500,000 lives, fosters improved healthcare access and quality through innovative partnerships, such as the collaboration with Stanford Health Plan. Investor Sentiment: Bullish sentiment surrounds OSCR, with long positions taken by sell-side firms and institutional investors like The Vanguard Group and Millennium Management LLC. Upgraded price targets from Bank of America Securities and Wells Fargo further bolster this positive sentiment. Robust Performance: OSCR's performance demonstrates strength, including a remarkable 40% year-over-year increase in total health plan membership, reaching 1.44 million, and a substantial 46% revenue growth to $2.1 billion in the latest quarter. CEO Endorsement: CEO Mark Bertolini highlighted strong membership retention, an increased Net Promoter Score (NPS) of 60%, and improved core ratios during the latest earnings call, further affirming OSCR's positive trajectory. Investment Outlook: Bullish Outlook: Given these positive indicators, a bullish stance on OSCR above $16.50-$17.00 appears justified. Upside Potential: With an upside target set at $34.00-$35.00, OSCR's growth potential in the health insurance market is poised for significant expansion. 📊🔍 Stay attuned to Oscar Health's progress for potential investment opportunities! #OSCR #HealthInsurance 🏥💼
NYSE:OSCRLong
by Richtv_official
UNH on watch for continuation after pullback LONGUNH after earnings with a mild beat in mid July, price shot up for one week then went sideways and then pulled back in the past week. Price is now at 497 and under the dynamic resistance of the first deviation line above the mean VWAP. The dual time frame shows a good pattern with the shorter TF of 3 minutes in green above the longer TF of 45 minutes in black. The short TF is above the 50 level. Overall, I think the pullback is about over. I will take a long trade with a buy stop of 500.25 setting the stop loss below what will become dynamic support of the blue line at 499.5. This is a tight stop and low risk owing to the positioning of the trade about a support level. I will target 515.00 for a risk to reward ratio of 0.75 to 15 or 1:20 which is outstanding. I may take a call option striking $510 out a couple of months if it would not draw down by the cash portion of my overall portfolio more than 3%. This option premium is about $9000 but I think the potential profit is about the same.
NYSE:UNHLong
by AwesomeAvani